Differential expression of serum proteins in chromic arsenic exposed population

Chinese Journal of Endemiology

Volumn 31, Issue 1, 2012, Pages 7-12

  Zhao, Li Jun ^a   Gao, Yan Hui ^a   Li, Yuan Yuan ^a   Feng, Hong Qi ^a   Wei, Wei ^a   Ding, Yun Peng ^a   Sun, Dian Jun ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Arsenic; Enviromental exposure; Mass spectrometry; Serum proteins; Two dimensional differential gel electrophoresis; Vulnerable population

Indexed keywords

APOLIPOPROTEIN; ARSENIC; BETA2 GLYCOPROTEIN 1; BIOLOGICAL MARKER; CARBOXYPEPTIDASE; CYTOKERATIN 1; DRINKING WATER; ESTROGEN RECEPTOR; FICOLIN; HEMOPEXIN; PLASMA PROTEIN; RETINOL BINDING PROTEIN;

ALCOHOL CONSUMPTION; ARTICLE; BLOOD SAMPLING; CATALYSIS; CHINA; CIGARETTE SMOKING; DOWN REGULATION; ENDEMIC DISEASE; EPITHELIUM; GEL ELECTROPHORESIS; HEALTH CARE; HUMAN; HYPOTHALAMUS; MASS SPECTROMETRY; POPULATION EXPOSURE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; QUESTIONNAIRE;

EID: 84863284234     PISSN: 10004955     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1000-4955.2012.01.003     Document Type: Article

References (15)

1. Balakumar P, Kaur J. Arsenic exposure and cardiovascular disorders: an overview[J]. Cardiovasc Toxicol, 2009,9(4):169-176.
2. Chen Y, Parvez F, Gamble M, et al. Arsenic exposure at low-to-moderate levels and skin lesions, arsenic metabolism, neurological functions, and biomarkers for respiratory and cardiovascular diseases: review of recent findings from the Health Effects of Arsenic Longitudinal Study (HEALS) in Bangladesh[J]. Toxicol Appl Pharmacol, 2009,239(2):184-192.
3. Rodriguez VM, Jiménez-Capdeville ME, Giordano M. The effects of arsenic exposure on the nervous system [J]. Toxicol Lett, 2003,145(1):1-18. (Pubitemid 38366125)
4. Schuhmacher-Wolz U, Dieter HH, Klein D, et al. Oral exposure to inorganic arsenic : evaluation of its carcinogenic and non-carcinogenic effects[J]. Crit Rev Toxicol, 2009,39(4):271-298.
5. Tannu NS, Hemby SE. Two-dimensional fluorescence difference gel electrophoresis for comparative proteomics profiling [J]. Nat Protoc, 2006,1(4):1732-1742. (Pubitemid 46778055)
6. Chen Y, Santella RM, Kibriya MG, et al. Association between arsenic exposure from drinking water and plasma levels of soluble cell adhesion molecules[J]. Environ Health Perspect, 2007,115(10):1415-1420. (Pubitemid 47618082)
7. Bernard A, Lauwerys R. Epidemiological application of early markers of nephrotoxicity[J]. Toxicol Lett, 1989,46(1-3):293-306. (Pubitemid 19084022)
8. Bernard A. Renal dysfunction induced by cadmium: biomarkers of critical effects[J]. Biometals, 2004,17(5):519-523. (Pubitemid 41214260)
9. Halatek T, Sinczuk-Walczak H, Rabieh S, et al. Association between occupational exposure to arsenic and neurological, respiratory and renal effects[J]. Toxicol Appl Pharmacol, 2009,239(2):193-199.
10. Nordberg GF, Jin T, Hong F, et al. Biomarkers of cadmium and arsenic interactions[J]. Toxicol Appl Pharmacol, 2005,206(2):191-197. (Pubitemid 40828238)
11. de Burbure C, Buchet JP, Leroyer A, et al. Renal and neurologic effects of cadmium, lead, mercury, and arsenic in children: evidence of early effects and multiple interactions at environmental exposure levels[J]. Environ Health Perspect, 2006,114(4):584-590.
12. Sun Y, Pi J, Wang X, et al. Aberrant cytokeratin expression during arsenic-induced acquired malignant phenotype in human HaCaT keratinocytes consistent with epidermal carcinogenesis [J]. Toxicology, 2009,262(2):162-170.
13. Chien CW, Chiang MC, Ho IC, et al. Association of chromosomal alterations with arsenite-induced tumorigenicity of human HaCaT keratinocytes in nude mice [J]. Environ Health Perspect, 2004,112(17):1704-1710.